Journals / Annals of Health Sciences Research / 2017 / Cilt: 6 - Sayı: 1

The Inhibition of Cerebral Vasospasm by Using Chelerythrine After Experimental Subarachnoidal Haemorrhage in Rats

Ratlarda Deneysel Subaraknoidal Kanama Sonrası Gelişen Serebral Vazospazmın, Seleritrin Kullanılarak Engellenmesi

Pages
18–22
Publication Date
2017-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Findings: The vasoconstriction of the basilar artery significantly attenuated in group 4 compared with the groups 2 and 3 p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Cerebral vasospasm, a devastating medical complication of aneurysmal subarachnoid hemorrhage SAH , is associated with high morbidity and mortality although a great deal of experimental and clinical research conducted to prevent this complication.
📊
Key Findings & Data:Methods: Twenty eight rats were divided into four groups: group 1; control, group 2; SAH, group 3; SAH plus placebo, and group 4; SAH plus chelerythrine chloride 5 µmol/kg/day .
💡
Conclusion & Impact:Findings: The vasoconstriction of the basilar artery significantly attenuated in group 4 compared with the groups 2 and 3 p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Sıçan · Subaraknoidal Kanama · Vazospazm

Abstract

Background: Cerebral vasospasm, a devastating medical complication of aneurysmal subarachnoid hemorrhage SAH , is associated with high morbidity and mortality although a great deal of experimental and clinical research conducted to prevent this complication. The most of the experimental results support the view that potent vasoconstrictor proteine kinase C PKC , plays a key factor in cerebral vasospasm. To inhibit vasospasm, we used a potent, selective, and cell-permeable protein kinase C PKC inhibitor chelerythrine chloride systemically in an experimental subarachnoidal hemorrhage SAH model. Methods: Twenty eight rats were divided into four groups: group 1; control, group 2; SAH, group 3; SAH plus placebo, and group 4; SAH plus chelerythrine chloride 5 µmol/kg/day . Chelerythrine chloride or an equal volume of 0.9 % saline was intraperitoneally administered for 5 days to groups 3 and 4, respectively. The rats were sacrificed on the fifth day. Sectioned slices were examined by light microscopy. Measurements were made for the cross-sectional areas of the lumen and the vessel wall of basilar artery in the sections of pons by a micrometer. Findings: The vasoconstriction of the basilar artery significantly attenuated in group 4 compared with the groups 2 and 3 p

Özet

Amaç: Önlenmesi için büyük çapta deneysel ve klinik araştırmalar yapılmış olmasına rağmen, anevrizmal subaraknoidal kanamanın SAK yıkıcı bir tıbbi komplikasyonu olan serebral vazospazm, yüksek oranda morbidite ve mortalite ile birliktedir. Deneysel sonuçların çoğu güçlü vazokonstrüktör protein kinaz C’nin PKC serebral vazospazmda anahtar bir rol oynadığı görüşünü desteklemektedir. Biz vazospazmı önlemek için, deneysel subaraknoidal kanama modelinde güçlü, selektif ve hücre içine geçebilen protein kinaz C PKC inhibitörünü seleritrin klorid sistemik olarak kullandık. Materyal ve Yöntem: Yirmi sekiz sıçan dört gruba ayrıldı: grup 1 kontrol grubu; grup 2, SAK grubu, grup 3, SAK artı plasebo grubu; ve grup 4, SAK artı chelerythrine chloride 5 µmol /kg/gün grubu ayrıldı. 3. ve 4. gruplara Seleritrin klorid veya eşit hacimde % 0.9 salin sırasıyla, intraperitoneal olarak 5 gün süreyle verildi. Sıçanlar beşinci günde sakrifiye edildi. Kesitler ışık mikroskobu ile incelendi. Pons seviyesinde yapılan kesitlerde, baziler arterin lümen alanı ve duvar kalınlığı ölçümleri mikrometre ile alındı. Bulgular: 4. gruptaki baziler arter daralması 2 ve 3 gruplarla karşılaştırıldığında, önemli ölçüde p

🔖

Cite This Article

ALADAG, M. A., YILDIZ, A., TURKOZ, Y., PARLAKPINAR, H. (2017). The Inhibition of Cerebral Vasospasm by Using Chelerythrine After Experimental Subarachnoidal Haemorrhage in Rats. Annals of Health Sciences Research, Cilt: 6 - Sayı: 1, 18–22. https://ajindex.com/articles/824824

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Nishizawa S, Chen D, Yokoyama T. et al. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase c activation, but does not contribute to prolonged vasospasm. Acta Neurochir (Wien) 2000; 142: 1409- 15. Laher I, Zhang JH. Protein Kinase C and Cerebral Vasospasm J Cereb Blood Flow Metab 2001; 21(8):887-906.
  2. Nishizawa S, Obara K, Nakayama K. et al. Protein kinase c delta and alpha are involved in the development of vasospasm after subarachnoid hemorrhage. Eur J Pharmacol 2000; 398:113–9.
  3. Hu N, Wu Y, Chen BZ. et al. Protective effect of stellate ganglion block on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage. Brain Res 2014; 1585: 63-71.
  4. Siuta M, Zuckerman SL, Mocco J. Nitric oxide in cerebral vasospasm: theories, measurement, and treatment. Neurol Res Int 2013;2013:972417. Miller BA, Turan N, Chau M. et al. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int 2014; 2014:384342. Huang CY, Wang LC, Shan YS. et al. Memantine attenuates delayed vasospasm after experimental subarachnoid hemorrhage via modulating endothelial nitric oxide synthase. Int J Mol Sci 2015; 16:14171-80.
  5. Laban KG, Vergouwen MD, Dijkhuizen RM. et al. Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 2015; 35: 1085-9.
  6. Chang CZ, Wu SC, Kwan AL. Glycyrrhizin attenuates Toll like receptor-2, −4 and experimental vasospasm in a rat model. J Immunol Res 2014; 2014: 740549. Banan A, Fields JZ, Farhadi A, et al: Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther 2002; 303:17-28.
  7. Dabrowski A, Boguslowicz C, Dabrowska M, et al: Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas 2000; 21; 376-84. Takao A: Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg 1999; 9: 303-18.
  8. Nishizawa S, Yamamoto S, Yokoyama T, et al: Dysfunction of nitric oxide induces protein kinase C activation resulting in vasospasm after subarachnoid hemorrhage. Neurol Res 1997;19: 558-62.
  9. Zhao D, Liu Q, Ji Y. et al. Correlation between nitric oxide and early brain injury after subarachnoid hemorrhage. Int J Neurosci 2015; 125(7)